Home   >  
Angiogenesis/Protein Tyrosine Kinase

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Btk inhibitor 1 R enantiomer hydrochloride Chemical Structure
BCP30305 Btk inhibitor 1 R enantiomer hydrochloride 1553977-42-6
Btk inhibitor 1R enantiomer Hcl is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.
QL47 Chemical Structure
BCP30763 QL47 1469988-75-7
QL47 is a potent, selective and irreversible BTK kinase inhibitor with IC50 of 7 nM.
BMX-IN-1 Chemical Structure
BCP30306 BMX-IN-1 1431525-23-3
BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
PCI-29732 Chemical Structure
BCP30138 PCI-29732 330786-25-9
PCI-29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.
(R)-Zanubrutinib Chemical Structure
BCP30082 (R)-Zanubrutinib 1691249-44-1
(R)-Zanubrutinib is the R enantiomer of Zanubrutinib. Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor.
Zanubrutinib Chemical Structure
BCP29110 Zanubrutinib 1691249-45-2
Zanubrutinib is a potent, selective and orally available Bruton's tyrosine kinase (Btk) inhibitor.
Vecabrutinib Chemical Structure
BCP29646 Vecabrutinib 1510829-06-7
Vecabrutinib, also known as SNS-062; FP-182, BSK-4841 and BIIB-062; is a potent, noncovalent, reversible BTK inhibitor that inhibits signaling through the BCR pathway.
BMS-986142 Chemical Structure
BCP29622 BMS-986142 1643368-58-4
BMS-986142 is a potent and highly selective reversible inhibitor of Bruton's tyrosine kinase (BTK) with an IC50 of 0.5 nM.
BMS-986195 Chemical Structure
BCP29496 BMS-986195 1912445-55-6
BMS-986195 is a potent, covalent, irreversible inhibitor of Bruton’s tyrosine kinase (BTK), with an IC50 of <1 nM.
ARQ-531 Chemical Structure
BCP29029 ARQ-531 2095393-15-8
ARQ-531 is a potent and orally active BTK inhibitor with potential antineoplastic activity.
123下一页末页共 32 条记录 1 / 4 页